Erste Asset Management

195 results for the topic "Equities"

ARTICLES IN THE TOPIC “Equities”

Miracle drug semaglutide: slim by injection
Miracle drug semaglutide: slim by injection
(c) unsplash

Miracle drug semaglutide: slim by injection

Originally, the Danish company Novo Nordisk wanted to develop Semaglutid as a drug for diabetes 2 patients. However, the appetite-reducing effect of the drug soon became apparent, making semaglutide a miracle cure for obesity. While Novo Nordisk’s share price has risen significantly since then, possible side effects of the drug are now also being examined.

Strong first half of the year: What`s next for the stock markets?
Strong first half of the year: What`s next for the stock markets?
(c) pexels

Strong first half of the year: What`s next for the stock markets?

The stock markets look back on a strong first half of the year. In addition to the already familiar factors of inflation and key interest rates, the trend topic of artificial intelligence (AI) came into focus. In this interview, fund manager Tamás Menyhárt looks back on the past six months and tells us what has to happen for 2023 to end as happily as the first half of the year did.

Benefit from the megatrend Artificial Intelligence with equities
Benefit from the megatrend Artificial Intelligence with equities
(c) unsplash

Benefit from the megatrend Artificial Intelligence with equities

The megatrend of artificial intelligence is also on everyone’s lips on the financial markets. Some companies from the AI sector have posted significant gains in their stock price so far this year. We show you with which investments you can profit from the AI boom and what you need to bear in mind.